Equities
Health CareHealth Care Equipment & Services
  • Price (USD)407.79
  • Today's Change8.62 / 2.16%
  • Shares traded1.36m
  • 1 Year change+2.59%
  • Beta0.8842
Data delayed at least 15 minutes, as of Sep 17 2021 21:10 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or via group Medicare accounts. The Group and Specialty segment consists of employer group commercial insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members as well as to third parties, including pharmacy solutions, provider services, and clinical care service, such as home health and other services and capabilities to promote wellness and population health.

  • Revenue in USD (TTM)80.45bn
  • Net income in USD2.48bn
  • Incorporated1964
  • Employees48.70k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 636-5454
  • Websitehttp://www.humana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HUM:NYQ since
announced
Transaction
value
One Homecare Solutions LLCAnnounced14 Jun 202114 Jun 2021Announced-2.72%--
Kindred at Home IncDeal completed27 Apr 202127 Apr 2021Deal completed-8.60%5.70bn
Data delayed at least 15 minutes, as of Sep 17 2021 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Agilon Health Inc-100.00bn-100.00bn11.34bn548.00--9.86----------2.94----------------------------0.0414--53.36--44.77------
Universal Health Services, Inc.12.21bn1.08bn12.13bn68.10k11.551.877.530.993412.6412.64142.7177.950.9784--7.57179,300.208.707.3110.578.62----8.907.541.1016.160.35334.681.595.0315.776.7014.128.45
Oak Street Health Inc1.12bn-313.04m12.65bn3.20k--58.08--11.33-1.43-1.435.080.90410.9887--3.55348,874.70-27.83---40.99--5.67---28.14-----63.060.8029--58.60---56.82------
Davita Inc11.57bn883.30m12.74bn67.00k15.8410.057.211.107.677.5099.5012.100.623274.396.22172,625.406.005.148.136.7531.4229.969.638.451.626.800.7567--1.42-3.4711.0323.77-0.9635--
Molina Healthcare, Inc.23.58bn632.00m16.24bn10.50k25.926.8121.860.688910.7310.73398.6140.862.56--13.722,245,524.006.874.5114.1310.7716.0315.902.681.84--8.900.49810.0015.416.50-8.6836.31-10.93--
Quest Diagnostics Inc11.06bn2.24bn18.91bn40.00k9.223.207.151.7116.7816.7882.6848.350.855536.509.29276,450.0017.457.6620.318.8541.7437.2920.4010.911.2618.290.399931.2822.154.7270.6615.089.718.50
Teladoc Health Inc1.63bn-763.32m22.80bn4.40k--1.43--14.00-5.66-5.6612.52100.340.1627--12.71370,215.20-7.62-6.58-7.78-6.7867.2267.06-46.86-36.033.79-6.710.0711--97.7169.85-390.71--27.21--
Laboratory Corp. of America Holdings16.39bn2.88bn28.53bn72.40k10.102.797.951.7429.2929.29166.76105.950.856526.356.50226,355.0015.055.7617.716.6538.6130.5517.588.351.9822.040.34980.0020.9810.0088.8928.888.33--
Centene Corp118.39bn720.00m37.69bn71.30k53.271.4518.240.31841.211.21202.3544.441.69----1,660,393.001.013.45--------0.5981.56--4.500.39120.0048.8737.3236.8738.4042.10--
Humana Inc80.45bn2.48bn52.40bn48.70k21.553.5317.200.651418.9218.92613.86115.512.10----1,651,951.006.247.96--------2.973.55--13.390.332911.8018.907.2824.3821.4213.0121.75
Cigna Corp166.89bn8.15bn69.93bn73.70k9.021.446.330.41922.7822.78468.41142.511.06----2,264,451.005.223.83--------4.914.63--6.170.40460.29224.2933.3865.7132.2116.490.00
HCA Healthcare Inc56.02bn4.97bn82.83bn127.00k17.75--9.771.4814.5814.58164.19-1.841.164.718.13441,070.9011.809.6816.1812.5183.7583.4510.218.031.216.490.94797.550.38385.377.1012.013.60--
Data as of Sep 17 2021. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD

Institutional shareholders

45.51%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20219.51m7.40%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 20219.45m7.36%
Fidelity Management & Research Co. LLCas of 30 Jun 20219.13m7.10%
Wellington Management Co. LLPas of 30 Jun 20215.84m4.54%
BlackRock Fund Advisorsas of 30 Jun 20215.69m4.43%
SSgA Funds Management, Inc.as of 30 Jun 20215.62m4.38%
Capital Research & Management Co. (International Investors)as of 30 Jun 20214.03m3.13%
Harris Associates LPas of 30 Jun 20213.36m2.62%
Capital Research & Management Co. (World Investors)as of 30 Jun 20213.26m2.54%
Capital Research & Management Co. (Global Investors)as of 30 Jun 20212.58m2.01%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image